{
  "url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2004/schedule-3/part-1",
  "json_url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2004/schedule-3/part-1.json",
  "legislation": "uksi/2004/2152",
  "legislation_title": "The Cosmetic Products (Safety) Regulations 2004",
  "legislation_url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2004",
  "path": "schedule/3/part/1",
  "kind": "part",
  "number": "1",
  "heading": "SUBSTANCES PROHIBITED IN ALL COSMETIC PRODUCTS",
  "text": "(1)\n(2)\n(3)\n(4)\nNumber in this Schedule\nName of substance\nCross-reference to this Schedule\nCross-reference to Annex II of the Directive\n1\nAcenocoumarol (INN)\n397\n254\n2\nAcetonitrile\n—\n393\n3\n3-(α-Acetonylbenzyl)-4-hydroxycoumarin and its salts\n399, 762\n203\n4\n2-Acetoxethyltrimethylammonium hydroxide and its salts\n6\n2\n5\n2-Acetylamino-5-chlorobenzoxazole\n163\n1\n6\nAcetylcholine and its salts\n4\n2\n7\nAcetylene chlorides\n250, 759\n126\n8\nAcetylenic alcohols, their esters, ethers and salts\n17\n16\n9\nAcetylethyltetramethyltetralin (AETT)\n342\n362\n10\n7α-Acetylthio-3-oxopregn-4-ene-17α,17β-propionolactone\n652\n4\n11\nAconitine and its salts\n—\n12\n12\nAconitum napellus L. (leaves, roots and galenical preparations)\n—\n11\n13\nAdonis vernalis L. and its preparations\n—\n13\n14\nAdrenaline\n270,315\n14\n15\nAlkali pentacyanonitrosylferrate(2-)-\n605-6, 647-8\n255\n16\nO-Alkyldithiocarbonic acids, salts of\n763\n336\n17\nAlkyne alcohols, their esters, ethers and salts\n8\n16\n18\nAlloclamide (INN) and its salts\n22\n18\n19\nAllyl isothiocynate\n—\n18\n20\n2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts\n—\n224\n21\nN-Allylnormorphine, its salts and ethers\n494\n20\n22\n2-Allyloxy-4-chloro-N-[2-(diethylamino)ethyl]-benzamide and its salts\n18\n19\n23\nAlypine and its salts\n45, 107\n143\n24\nAmbenonium chloride (INN)\n(529)\n132\n25\n4-(or p-)Aminobenzonic acid esters\n—\n167\n26\n2-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts\n—\n29\n27\nAminocaproic acid (INN) and its salts\n31\n7\n28\n2-Amino-5-chlorobenzoxazole\n769\n24\n29\n4-Amino-N-(2-diethylaniaminoethyl)benzamide, its salts and derivatives\n610\n25\n30\nAminoheptane, its isomers and salts\n751\n25\n31\n6-Aminohexanoic acid and its salts\n27\n7\n32\nα-(Aminomethyl)-3,4-dihydroxybenzyl alcohol and its salts\n519-520\n257\n33\n4-Amino-N1o-methylfolic acid\n452\n6\n34\n2-Amino-6-methylheptane and its salts\n288, 525\n28\n35\n2-Amino-4-methylhexane and its salts\n289, 471\n30\n36\n2-Amino-4-nitrophenol\n—\n383\n37\n2-Amino-5-nitrophenol\n—\n384\n38\n4-Amino-2-nitrophenol\n—\n412\n39\n4-(or p-)Aminosalicylic acid and its salts\n—\n31\n40\nAminotoluenes, their isomers, salts and halogenated and sulphonated derivatives\n719\n32\n41\nAminoxylenes, their isomers, salts and halogenated and sulphonated derivatives\n765\n33\n42\nAmitriptyline (INN) and its salts\n284\n146\n43\nAmmi majus and its galenical preparations\n—\n35\n44\nAmphetamine (INN), its salts and derivatives and salts of those derivatives\n(681)\n21\n45\nAmydricaine and its salts\n23, 107\n143\n46\nAmylene chloride\n251\n36\n47\nAmyl 4-dimethylaminobenzoate, mixed isomers\n534\n381\n48\nAmyl nitrites\n—\n247\n49\nAmylobarbitone and its salts\n(69)\n220\n50\nAmylocaine and its salts\n282\n50\n51\nAnamirta cocculus L. (fruit)\n—\n106\n52\nSubstances with androgenic effect\n—\n37\n53\nAniline, its salts and halogenated and sulphonated derivatives\n—\n22\n54\nAnthracene oil\n—\n38\n55\nAnti-androgens with steroid structure\n—\n390\n56\nAntibiotics\n—\n39\n57\nAntimony and its compounds\n—\n40\n58\nApocynum cannabinum L. and its preparations\n—\n41\n59\nApomorphine and its salts\n697\n42\n60\nApronalide\n420\n216\n61\nArecoline\n482\n238\n62\nAristolochic acid and its salts\n—\n365\n63\nArsenic and its preparations\n—\n43\n64\nAtropa belladonna L. and its preparations\n—\n44\n65\nAntropine, its salts and derivatives\n—\n45\n66\nAzacyclonol (INN) and its salts\n305\n286\n67\nAzamethonium bromide (INN)\n(473)\n121\n68\nBarbitone and its salts\n(69)\n220\n69\nBarbiturates\nvarious\n220\n70\nBarium salts (except barium sulphate, barium sulphide under the condition laid down in Part I of Schedule 4 for alkaline earth sulphides, and lakes, salts and pigments prepared from those colouring agents identified in column 1 of Schedule 5 by “*” immediately after the name or colour index number)\n—\n46\n71\nBemegride (INN) and its salts\n337, 338\n183\n72\nBenactyzine (INN)\n258\n157\n73\nBendrofluazide and its derivatives\n74, 89\n53\n74\nBendroflumethiazide (INN) and its derivatives\n73, 89\n53\n75\nBenzamine and its salts\n744\n51\n76\nBenzatropine (INN) and its salts\n301\n158\n77\nBenzazepines, their salts and derivatives\n88\n49\n78\nBenzene\n—\n47\n79\nBenzene-1,2-diol\n152, 630\n408\n80\nBenzene-1,2,3-triol\n631\n409\n81\n2-Benzhydryloxyethyldimethylamine and its salts\n296\n339\n82\nBenzidine\n243\n26\n83\nBenzilonium bromide (INN)\n93\n60\n84\n2-Benziloyloxymethyl-1,1-dimethylpyrrolidinium methyl sulphate\n602\n239\n85\nBenzimidozolone\n86, 267\n48\n86\nBenzimidazol-2(3H)-one;\n85, 267\n48\n87\nBenzoates of 4-hydroxy-3-methoxycinnamyl alcohol (except natural content of essences)\n211\n357\n88\nBenzodiazepines, their salts and derivatives\n77\n49\n89\nBenzothiadiazine and its derivatives\n73, 74\n53\n90\nENTRY DELETED\n91\n3-(N-Benzylhydrazinocarbonyl)-5-methylisoxazole\n415\n52\n92\nBenzylideneacetone\n567\n356\n93\n3-Benzyloxy-1,1-diethylpyrrolidine hydrobromide\n83\n60\n94\n4-Benzyloxyphenol\n(391), 487\n178\n95\n2-[Benzyl-N-(2-pyridyl)amino]ethyldimethylamine\n626, 748\n347\n96\nBergapten(e) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg\n(357)\n358\n97\nBeryllium and its compounds\n—\n54\n98\nBetamethasone (INN)\n(361)\n300\n99\nBetoxycaine (INN) and its salts\n257\n23\n100\nBHC (ISO) (gamma-BHC)\n370, 372, 428\n195\n101\nBietammiverine (INN)\n261\n287\n102\n1,6-Bis(2-chloroethylamino)-1,6-dideoxymannitol and its salts\n436\n89\n103\n2-[Bis(2-chloroethyl)amino]-1-oxa-3-aza-2-phosphacyclohexane 2-oxide and its salts\n106, 231\n88\n104\nN,N-Bis(2-chloroethyl)methylamine and its salts\n159 492\n87\n105\nN,N-Bis(2-chloroethyl)methylamine N-oxide and its salts\n493\n86\n106\nN,N-Bis(2chloroethyl)-1,3,2-oxazaphosphinan-2-ylamine P-oxide and its salts\n103, 231\n88\n107\n1,1-Bis(dimethylaminomethyl)propyl benzoate and its salts\n23, 45\n143\n108\nBis(hydroxyalkyl)amines, not further N-substituted\n255, 274, (643)\n411\n109\n2,2-Bis(hydroxymethyl)butan-1-ol trinitrate\n616\n206\n110\n2,6-Bis(β-hydroxyphenethyl)-1-methylpiperidine and its salts\n430\n219\n111\n3,3-Bis(4-hydroxyphenyl)phthalide\n560\n417\n112\nBis(8-hydroxyquinolinium) sulphate, except for the uses provided for in entry number 51 in Part 1 of Schedule 4\n(401, 533)\n395\n113\nBithionol (INN)\n708\n352\n114\nBretylium tosilate (INN) (Bretylium tosylate)\n117\n56\n115\nBromine, elemental\n—\n55\n116\nBromisoval (INN)\n119\n58\n117\np-Bromobenzylethyldimethylammonium\np-toluenesulphonate\n114\n56\n118\n2-Bromo-2-ethylbutyrylurea\n148\n57\n119\n2-Bromo-3-methylbutylrylurea\n116\n58\n120\n1-p-Bromophenyl-l-(2-pyridyl)-3-dimethylaminopropane and its salts\n121\n59\n121\nBrompheniramine (INN) and its salts\n120\n59\n122\nBrucine\n—\n62\n123\nButanilicaine (INN) and its salts\n466\n90\n124\nButobarbitone and its salts\n(69)\n220\n125\nButopiprine (INN) and its salts\n127\n288\n126\n2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide and its salts\n190\n129\n127\n2-Butoxyethyl phenyl(piperidino)acetate and its salts\n125\n288\n128\n1-Butyl-3-(N-crotonoylsulphanilyl)urea\n—\n108\n129\n4-Butyl-1,2-diphenylpylpyrazolidine-3,5-dione\n566\n67\n130\n4-tert-Butyl-3-methhoxy-2,6-dinitrotoluene\n490\n414\n131\n4-Butyl-l-phenylpyrazolidine-3,5-dione\n486\n64\n132\n1-Butyl-3-(p-methylenzenesulphonyl)urea\n718\n65\n133\n1-Butyl-3-sulphanilylurea\n149\n66\n134\n4-Butylthiobenzhydryl 2-(dimethylamino)ethyl sulphide\n142\n140\n135\n1-tert-Butyl-3,4,5-trimethyl-2,6-dinitrobenzene\n491\n422\n136\nCadmium and its compounds\n—\n68\n137\nCalabar bean\n588\n281\n138\nCalciferol\n317, (761)\n335\n139\nCantharides, Cantharis vesicatoria\n650\n69\n140\nCantharidin\n379\n70\n141\nCaptan (ISO)\n737\n370\n142\nCaptodiame (INN)\n134\n140\n143\nCaramiphen (INN) and its salts\n570\n169\n144\nN-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethylammonium salts\n419\n156\n145\nCarbazole, nitroderivatives of\n510\n72\n146\nCarbon disulphide\n—\n73\n147\nCarbon tetrachloride\n693\n315\n148\nCarbromal (INN)\n118\n57\n149\nCarbutamide (INN)\n133\n66\n150\nCarisoprodol (INN)\n480\n235\n151\nCatalase\n—\n74\n152\nCatechol\n79, 630\n408\n153\nCells, tissues or products of human origin\n—\n416\n154\nCephaeline and its salts\n—\n75\n155\nChenopodium ambrosioides (essential oil)\n—\n76\n156\nCherry laurel water\n621\n291\n157\nChloral hydrate\n735\n77\n158\nChlorine\n—\n78\n159\nChlormethine (INN) and its salts\n104, 492\n87\n160\nChlormezanone (INN)\n174\n91\n161\n4-Chlorobenzene-1,3-disulfonamide\n193\n85\n162\n5-Chloro-1,3-benzoxazol-2(3H)-one\n185\n82\n163\nN-5-Chlorobenzoxazol-2-ylacetamide\n5\n1\n164\n2-Chloro-9-[3-dimethylamino-6-methylpyrimidine\n168, 216,\n83\n165\n2-Chloro-9-[3-(dimethylamino)-propylidene]thioxanthene (cis-form) and its salts\n182\n84\n166\nChloroethane\n328\n96\n167\nChloroform\n737\n366\n168\n2-Chloro-6-methylpyrimidin-4-yldimethylamine\n164, 216\n83\n169\nChlorophacinone (ISO)\n175\n93\n170\n1-(p-Chloro-α-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine\n402\n240\n171\n2-(4-Chlorophenyl)-1-[4-2-diethyl-aminoethoxyl)]phenyl-1-p-tolyethanol\n747\n92\n172\n4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one\n369\n185\n173\n2-(4-Chlorophenyl)-3-methylbutane-2,3-diol\n554\n95\n174\n2-(4-Chlorophenyl-3-methyl-1,3-thiazinan-4-one 1,1-dioxide\n160\n91\n175\n2-[2-(4-Chlorophenyl)-2-phenylacetyl]indane-1,3-dione\n169\n93\n176\n2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl-(dimethyl)amine\n179\n94\n177\nChloropicrin\n738\n325\n178\n3-(4-Chloro-3-sulphamoylphenyl)-3-hydroxyisoindolin-1-one\n183, 184\n262\n179\nChlorphenoxamine (INN)\n176\n94\n180\nChlorpromazine (INN)\n(561)\n320\n181\nChlorpropamide (INN)\n617\n79\n182\nChlorprohixene (INN) and its salts\n165\n84\n183\nChlortalidone (INN)\n178, 184\n262\n184\nChlorthalidone\n178, 184\n262\n185\nChlorzoxazone (INN)\n162\n82\n186\nCholecalciferol\n(761)\n335\n187\nCholine salts and their esters\n—\n168\n188\nChromium, chromic acid and salts of the acid\n—\n97\n189\nChrysoidine citrate hydrochloride\n565\n81\n190\nCinchocaine (INN) and its salts\n126\n129\n191\nCincophen (INN), its salts and derivatives and salts of those derivatives\n580\n8\n192\nClaviceps purpurea Tul., its alkaloids and galenical preparations\n318\n98\n193\nClofenamide (INN)\n161\n85\n194\nClofenotane (INN)\n734\n123\n195\nCoal tar, crude and refined\n218\n420\n196\nCobalt benzenesulphonate\n—\n101\n197\nCocculin\n592\n282\n198\nColchicine, its salts and derivatives\n—\n102\n199\nColchicoside and its derivatives\n—\n103\n200\nColchicum automnale L, and its galenical preparations\n—\n104\n201\nColouring agent CI 12075 and its lakes, pigments and salts\n—\n397\n202\nColouring agent CI 12140\n—\n378\n203\nColouring agent CI 13065\n—\n387\n204\nColouring agent CI 15585\n—\n401\n205\nColouring agent CI 26105\n—\n379\n206\nColouring agent CI 42535\n—\n388\n207\nColouring agents CI 42555, 42555:1 and 42555:2\n—\n380\n208\nColouring agent CI 42640\n—\n386\n209\nColouring agent CI 45170 and CI 45170:1\n—\n398\n210\nColouring agent CI 61554\n—\n389\n211\nConiferyl benzoate (except natural content of essences)\n87\n357\n212\nConiine\n618\n290\n213\nConium maculatum L. (fruit, powder, galenical preparations)\n—\n99\n214\nConvallatoxin\n—\n105\n215\nCoumetarol (INN)\n454\n225\n216\nCrimidine (ISO)\n164, 168\n83\n217\nCroton tiglium (oil)\n—\n107\n218\nCrude and refined coal tars\n195\n420\n219\nCurare and curarine\n—\n109\n220\nCurarizants, synthetic\n—\n110\n221\n1-(3-Cyano-3,3-diphenylpropyl)-4-ethoxycarbonyl-4-phenylpiperidinium chloride\n297\n80\n222\nCyclarbamate (INN)\n230\n122\n223\nCyclizine (INN) and its salts\n302\n159\n224\nCyclobarbitone and its salts\n(69)\n220\n225\nCyclocoumarol\n268\n234\n226\n2-a-Cyclohexylbenzyl(N,N,N’,N’-tetraethyl)trimethylenediamine\n555\n112\n227\n2-Cyclohexyl-3,5-dimethylphenol and its salts\n229\n113\n228\nCyclohexyl-3-(p-methylbenzenesulphonyl)urea\n364\n100\n229\nCyclomenol (INN) and its salts\n227\n113\n230\nCyclopentane-1,1-dimethanol dicarbanilate\n222\n122\n231\nCyclophosphamide (INN) and its salts\n103, 106\n88\n232\nDatura stranibuyn L. and its galenical preparations\n54\n301\n233\nDDT (ISO) (pp’-DDT)\n194 734\n123\n234\nDeanol aceglumate (INN)\n279\n3\n235\nDecamethonuium bromide (INN)\n(236)\n214\n236\nDecamethylene-bis(trimethylammonium) salts\n235\n214\n237\nDextromethorphan (INN) and its salts\n457\n226\n238\nDextropropoxyphene (INN)\n281\n116\n239\nO,O’-Diacetyl-N-allyl-N-normorphine\n—\n117\n240\n2,4-Diaminoanisole and its salts\n455, 461\n376\n241\n2,5-Diaminoanisole and its salts\n456, 460\n377\n242\n1,2-Diaminobenzene and its salts\n573\n363\n243\np,p’-Diaminodiphenyl\n82\n26\n244\n2-(2,4-Diaminophenyl)ethanol and its salts\n—\n407\n245\n1,4:3,6-Dianhydrosorbitol 2,5-dinitrate\n422\n148\n246\n5-(α,β-Dibromophenethyl)-5-methylhydantoin\n—\n119\n247\nDibromosalicylanilides\n248, 443\n351\n248\nDibromsalan (INN)\n(247)\n351\n249\nDichloroethanes\n330, 335\n125\n250\nDichloroethylenes\n7, 759\n126\n251\n2,3-Dichloro-2-methylbutane\n46\n36\n252\nDichlorosalicylanilides\n—\n349\n253\nDicoumarin\n254, 469\n231\n254\nDicoumarol (INN)\n253, 469\n231\n255\nDiethanolamine\n(108, 643)\n411\n256\n2-Diethylaminoethoxy)ethyl\nα-phenylpiperidine-1-acetate dimethiodide\n601\n137\n257\n2-Diethylaminoethyl 3-amino-4-butoxybenzoate and its salts\n99\n23\n258\n2-Diethylaminoethyl benzilate\n72\n157\n259\n2-Diethylaminoethyl 4-ethoxybenzoate and its salts\n411, 538\n179\n260\n2-Diethylaminoethyl 3-hydroxy-4-phenylbenzoate and its salts\n—\n128\n261\n2-Diethylaminoethyl phenyl(piperidino)acetate\n101\n287\n262\n3-Diethylaminopropyl cinnamate\n—\n130\n263\nDiethyl 4-nitrophenyl phosphate\n536\n170\n264\nO,O-Diethyl O-4-nitrophenyl phosphorothioate\n537\n131\n265\nDifencloxazine INN)\n569\n270\n266\nDigitaline and all heterosides of Digitalis purpureaL.\n—\n134\n267\n4.5-Dihydrobenzimidazol-4-one\n85 86\n48\n268\n3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano[3,2-c]-[1]]-benzopyran-5-one\n225\n234\n269\nDihydrotachacysterol (INN)\n–\n342\n270\n3,4-Dihydroxy-α-(methylaminomethyl)benzyl alcohol\n14, 315\n14\n271\n4,4’-Dihydroxy-3,3’-(3-methylthiopropylideneI)dicoumarin\n–\n207\n272\n1-(3,4-Dihydroxyphenyl)-2-ethylaminopropan-1-ol and its salts\n294\n136\n273\n1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol\n418, 421\n17\n274\nDiisopropanolamine\n(108, 643)\n411\n275\n5,5’-Di-isopropyl-2,2’-dimethylbiphenyl-4,4’-diyldihypoiodite\n413\n361\n276\nDimethoxane\n286\n368\n277\n4-[2-(3,4-Dimethoxyphenyl)ethyl]-1-(2-chlorophenyl)piperazine and its salts\n438\n141\n278\nDimethylamine\n—\n142\n279\n2-Dimethylaminoethyl N-acetylglutamate\n234\n3\n280\n2-Dimethylaminoethyl p-butylaminobenzoate and its salts\n690\n63\n281\n(+)-4-Dimethylamino-3-methyl-1,2-diphenyl-2-propionyloxybutane\n238\n116\n282\n1-Dimethylaminomethyl-1-methylpropyl benzoate and its salts\n50\n50\n283\n2-Dimethylaminopropiophenone and its salts\n445\n145\n284\n3-(3-Dimethylaminopropylidene)-1,2,4,5-dibenzocyclohepta-1,4-diene and its salts\n42\n146\n285\n1,1-Dimethylbiguanide and its salts\n447\n147\n286\n2,6-Dimethyl-1,3-dioxan-4-yl- acetate\n276\n368\n287\nDimethylformamide\n–\n355\n288\n1,5-Dimethylhexylamine and its salts\n34, 525\n28\n289\n1,3-Dimethylpentylamine and its salts\n35, 471\n30\n290\nDimethyl sulfoxide (INN)\n—\n338\n291\nDimevamide (INN) and its salts\n298\n153\n292\nDinitrophenol isomers\n—\n151\n293\nDioxane\n—\n343\n294\nDioxethedrin (INN) and its salts\n272\n136\n295\n2,5-Dioxo-3,3-diethyl-5-methylpiperidine and its salts\n483\n133\n296\nDiphenhydramine (INN) and its salts\n81\n339\n297\nDiphenoxylate hydrochloride (INNM)\n221\n80\n298\n2,2-Diphenyl-4-dimethylaminovaleramide and its salts\n291\n153\n299\n5,5-Diphenyl-4-imidazolidone\n—\n160\n300\n4-Diphenylmethoxy-1-methylpiperidine and its salts\n306\n154\n301\n3-Diphenylmethoxytropane and its salts\n76\n158\n302\n1-Diphenylmethyl-4-methylpiperazine and its salts\n223\n159\n303\n1,2-Diphenyl-4-(2-phenylsulphinylethyl)-pyrazolidine-3,5-dione\n664\n155\n304\nα,α-Diphenyl-2-piperidinemethanol and its salts\n600\n285\n305\nα,α-Diphenyl-4-piperidinemethanol and its salts\n66\n286\n306\nDiphenylpyraline (INN) and its salts\n300\n154\n307\n2,5-Dipropoxy-3,6-bis(ethyleneimino)-1,4-benzoquinone\n410\n152\n308\n4-Dipropylsulphamoylbenzoic acid\n609\n161\n309\nDisulfiram (INN)\n702, 713\n162\n310\nDithio-2,2’-bis(pyridine 1-oxide) 1,1’ (additive with trihydrated magnesium sulphate)\n628\n396\n311\nDoxylamine (INN) and its salts\n579\n176\n312\nEmetine, its salts and derivatives\n—\n163\n313\nEndrin (ISO)\n373\n196\n314\nEphedrine and its salts\n—\n164\n315\nEpinephrine (INN)\n14, 270\n14\n316\n1,2-Epoxybutane\n—\n400\n317\nErgocalciferol (INN)\n138 (761)\n335\n318\nErgot and its alkaloids\n192\n98\n319\nEserine and its salts\n589\n166\n320\nEthionamide (INN)\n336\n319\n321\nEthoheptazine (INN) and its salts\n476\n173\n322\nEthopropazine and its salts\n(561)\n320\n323\n4-Ethoxyphenol\n(391)\n178\n324\n4-Ethoxy-m-phenylenediamine and its salts\n—\n406\n325\n2-Ethylamino-5-phenyloxazolin-4-one\n345\n180\n326\nEthyl bis(4-hydroxycoumarinyl)acetate and salts of the acid\n327\n204\n327\nEthyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid\n326\n204\n328\nEthyl chloride\n166\n96\n329\nEthyl 1,3-dimethyl-4-phenylazepane-4-carboxylate and its salts\n446\n171\n330\nEthylene dichloride\n(249)\n125\n331\nEthylene oxide\n—\n182\n332\n2-Ethyl-2,3-epoxyhexamide and its derivatives\n530\n165\n333\nEthyl p-fluorophenyl sulphone\n348\n189\n334\nEthyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate and its salts\n532\n172\n335\nEthylidene dichloride\n(249)\n125\n336\n3-Ethylisothionicotinamide\n320\n319\n337\n3-Ethyl-3-methylglutarimide and its salts\n71, 338\n183\n338\n4-Ethyl-4-methylpiperidine-2,6-dione and its salts\n71, 337\n183\n339\n2-Ethyl-3-methylvaleramide\n755\n184\n340\nEthylphenacemide\n556, 568\n272\n341\n2-Ethyl-2-phenylglutarimide and its salts\n362\n181\n342\n3’-Ethyl-5’,6’,7’,8’-tetrahydro-5’,5’,8’,8’-tetramethyl-2’-acetonaphthone\n9\n362\n343\nEthyl urocanate\n(406)\n418\n344\nFenadiazole (INN)\n528\n208\n345\nFenozolone (INN)\n325\n180\n346\nFenyramidol (INN)\n578, 582\n274\n347\nFluanisone (INN)\n351\n187\n348\nFluoresone (INN)\n333\n189\n349\n4’-Fluoro-4-[4-hydroxy-4-(α,α,α-trifluoro-m-tolyl)piperino]butyrophenone\n741\n188\n350\n6-Fluoro-16-methyl-11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione\n535\n186\n351\n1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]butan-1-one\n347\n187\n352\n5-Fluoropyrimidine-2,4-dione\n353\n190\n353\nFluorouracil (INN)\n352\n190\n354\nFluphenazine (INN)\n(561)\n320\n355\nFurazolidone (INN)\n513\n252\n356\nFurfuryltrimethylammonium salts\n358\n192\n357\nFurocoumarins (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg\n96, 462, 623, 746\n358\n358\nFurtrethonium iodide (INN)\n(356)\n192\n359\nGalantamine (INN)\n—\n193\n360\nGallamine triethiodide (INN)\n518\n329\n361\nGlucocorticoids\n98\n300\n362\nGlutethimide (INN) and its salts\n341\n181\n363\nGlycerol trinitrate\n514, 615\n253\n364\nGlycyclamide (INN)\n228\n100\n365\nGold salts\n—\n296\n366\nGuaifenesin (INN)\n459\n230\n367\nGuanethidine (INN) and its salts\n368\n259\n368\nN-(2-Guanidinoethyl)azocane and its salts\n367\n259\n369\nHaloperidol (INN)\n172\n185\n370\nHCH (ISO) (gamma-HCH)\n100, 372, 428\n195\n371\nHETP\n378\n316\n372\n1,2,3,4,5,6-Hexachlorocyclohexane\n100, 370, 428\n195\n373\n(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8 dimethanonaphthalene\n313\n196\n374\nHexachloroethane\n—\n197\n375\n3,3’4,4’6,6’-Hexachloro-2,2’-methylenediphenol\n376\n371\n376\nHexachlorophene (INN)\n375\n371\n377\n(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene\n416\n198\n378\nHexaethyl tetraphosphate\n371\n316\n379\n(1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride\n140\n70\n380\n(3S,5aR,9bS)-3,3a,4,5,5a,9b-Hexahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8-dione\n639\n217\n381\nHexamethonium bromide (INN)\n(382)\n124\n382\nN-N’-Hexamethylenebis(trimethylammonium) salts\n381\n124\n383\nHexapropymate (INN)\n619\n115\n384\nHydrastine, hydrastinine and their salts\n—\n199\n385\nHydrazides and their salts\n—\n200\n386\nHydrazine, its derivatives and their salts\n—\n201\n387\n2-Hydrazino-octane and its salts\n523\n202\n388\nHydrocyanic acid and its salts\n390, 409, 604\n111\n389\nHydrofluoric acid, its normal salts, complexes and hydrofluorides (except those listed in Part I of Schedule 4)\n—\n191\n390\nHydrogen cyanide and its salts\n388, 409, 604\n111\n391\nHydroquinone monobenzyl and monoethyl ethers\n487\n178\n392\n7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline\n764\n135\n393\n[4-[4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl] acetic acid and its salts\n742\n5\n394\n3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propionic acid and its salts\n716\n9\n395\n2-Hydroxy-3-(2-methoxyphenyl)propyl carbamate\n450\n205\n396\n1-Hydroxymethyl-1-cyclohexcylacetic acid, sodium salt\n646\n114\n397\n4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]coumarin\n1\n254\n398\n8-Hydroxy-5-nitroquinoline and its salts\n517\n209\n399\n4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin and its salts\n3, 762\n203\n400\n11α-Hydroxypregn-4-ene-3,20-dione and its esters\n—\n385\n401\nHydroxy-8-quinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 4\n112, 533, 633\n395\n402\nHydroxyzine (INN)\n170\n240\n403\nHyoscine, its salts and derivatives\n641\n295\n404\nHyoscyamine, its salts and derivatives\n—\n210\n405\nHyoscyamus niger L. (leaves, seeds, powder and galenical preparations)\n—\n211\n406\n3-Imidazol-4-ylacrylic acid and its ethyl ester\n343, 753\n418\n407\n2-Imino-5-phenyloxazolidin-4-one and its salts\n540\n212\n408\nImperatorin\n465\n34\n409\nInorganic cyanides\n(388, 390), 604\n111\n410\nInproquone (INN)\n307\n152\n411\nIntracaine and its salts\n259, 538\n179\n412\nIodine\n—\n213\n413\nIodothymol\n275\n361\n414\nIpecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations)\n—\n215\n415\nIsocarboxazid (INN)\n91\n52\n416\nIsodrin\n377\n198\n417\nIsometheptene (INN) and its salts\n463\n228\n418\nIsoprenaline (INN)\n273, 421\n17\n419\nIsopropamide iodide (INN)\n(144)\n156\n420\n(2-Isopropylpent-4-enoyl)urea\n60\n216\n421\nIsoproterenol\n273, 418\n17\n422\nIsosorbide dinitrate (INN)\n245\n148\n423\nJuniperus Sabina L (leaves, essential oil and galenical preparations)\n—\n294\n424\nLaurus nobilis L. (oil from seeds)\n—\n359\n425\nLead and its compounds (except lead acetate subject to the restrictions laid down in entry number 55 in Part I of Schedule 4)\n—\n289\n426\nLevophacetoperane and its salts\n597\n284\n427\nLidocaine (INN) (Lignocaine)\n—\n399\n428\nLindane\n100, 370, 372\n195\n429\nLobelia inflata L. and its galenical preparations\n—\n218\n430\nLobeline (INN) and its salts\n110\n219\n431\nLSD\n(433 434)\n127\n432\nLupinidine and its salts\n651\n299\n433\nLysergic acid diethylamide and its salts\n431, 434\n127\n434\nLysergide (INN) and its salts\n431, 433\n127\n435\nMalononitrile\n—\n149\n436\nMannomustine (INN) and its salts\n102\n89\n437\nMecamylamine (INN)\n701\n229\n438\nMefeclorazine (INN) and its salts\n277\n141\n439\nMephenesin (INN) and its esters\n721\n322\n440\nMeprobamate (INN)\n481\n236\n441\nMercury and its compounds (except those listed in Part I of Schedule 6)\n—\n221\n442\nMescaline and its salts\n743\n222\n443\nMetabromsalan (INN)\n(247)\n351\n444\nMetaldehyde\n603\n223\n445\nMetamfepramone (INN) and its salts\n283\n145\n446\nMetethoheptazine (INN) and its salts\n329\n171\n447\nMetformin (INN) and its salts\n285\n147\n448\nMethapyrilene (INN) and its salts\n627\n144\n449\nMetheptazine (INN) and its salts\n468\n174\n450\nMethocarbamol (INN)\n395\n205\n451\nMethohexitone and its salts\n(69)\n220\n452\nMethotrexate (INN)\n33\n6\n453\n2-[4-Methoxybenzyl-N-(2-pyridyl)amino]-ethyldimethylamine maleate\n625\n346\n454\n1-Methoxy-2,2-bis(4-hydroxy-3-coumarinyl)ethane\n215\n225\n455\n1-Methoxy-2,4-diaminobenzene and its salts\n240, 461\n376\n456\n1-Methoxy-2,5-diaminobenzene and its salts\n241, 460\n377\n457\n(+)-3-Methoxy-N-methylmorphinan and its salts\n237\n226\n458\nENTRY DELETED\n459\n3-(2-Methoxyphenoxy)propane-1,2-diol\n366\n230\n460\n2-Methoxy-p-phenylenediamine and its salts\n241, 456\n377\n461\n4-Methoxy-m-phenylenediamine and its salts\n240, 455\n376\n462\nMethoxypsoralens (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg\n(357)\n358\n463\n6-Methylamino-2-methylhept-2-ene and its salts\n417\n228\n464\n2-Methyl-1,2-bis(3-pyridyl)propan-1-one\n484\n292\n465\n9-(3-Methylbut-2-enyloxy)furo-[3,2-g]chromen-7-one\n408\n34\n466\n2-Methyl-6-chloroanilide of n-butylaminoacetic acid and its salts\n123\n90\n467\n1-Methyl-2,4-diaminobenzene and its salts\n477\n364\n468\nMethyl 1,2-dimethyl-4-phenylazepane-4-carboxylate and its salts\n449\n174\n469\n3,3-Methylenebis-(4-hydroxycoumarin)\n253, 254\n231\n470\n2-Methylheptylamine and its salts\n—\n227\n471\n4-Methyl-2-hexylamine and its salts\n35, 289\n30\n472\n1-Methylimidazole-2-thiol\n474, 707\n233\n473\nN,N’ [Methylimino)diethylene]bis-(ethyldimethylammonium) salts\n67\n121\n474\n1-Methyl-2-mercaptoimidazole\n472, 707\n233\n475\nMethylphenidate (INN) and its salts\n575\n175\n476\n1-Methyl-4-phenyl-4-carbethoxyhexa-methyleneimine and its salts\n321\n173\n477\n4-Methyl-m-phenylenediamine and its salts\n467\n364\n478\n2-Methyl-m-phenylenediamine\n—\n413\n479\n3-Methyl-2-phenylmorpholine, its derivatives and salts\n558\n232\n480\n2-Methyl-2-propyl-1-isopropylcarbamoyloxy-3-carbamoyloxypropane\n150\n235\n481\n2-Methyl-2-propyltrimethylene dicarbamate\n440\n236\n482\nN-Methyl-1,2,5,6-tetrahydro-3-nicotine acid methyl ester\n61\n238\n483\nMethyprylon (INN) and its salts\n295\n133\n484\nMetyrapone (INN)\n464\n292\n485\nMinoxidil (INN), its salts and derivatives\n599\n372\n486\nMofebutazone (INN)\n131\n64\n487\nMonobenzone (INN)\n94, (391)\n178\n488\nMorpholine and its salts\n—\n344\n489\nMoskene\n546\n421\n490\nMusk ambrette\n130\n414\n491\nMusk tibetene\n135\n422\n492\nMustine and its salts\n104, 159\n87\n493\nMustine N-oxide and its salts\n105\n86\n494\nNalorphine (INN), its salts and ethers\n21\n20\n495\nNaphazoline (INN) and its salts\n501\n244\n496\n2-Naphthol\n497\n241\n497\nβ-Naphthol\n496\n241\n498\n1-and 2-Naphthylamines and their salts\n499\n242\n499\nα-and β-Naphthylamines and their salts\n498\n242\n500\n3-(1-Naphthyl)-4-hydroxycoumarin\n—\n243\n501\n2-(1-Naphthylmethyl)-2-imidazoline and its salts\n495\n244\n502\nNarcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on Narcotic Drugs 1961 (Treaty Series No. 34 (1965), Cmnd. 2631)\n—\n306\n503\nNarcotine and its salts\n521\n258\n504\nNeodymium and its salts\n—\n309\n505\nNeostigmine and its salts\n—\n245\n506\nNicotine and its salts\n—\n246\n507\nNitrites, inorganic (except sodium nitrite)\n—\n248\n508\nNitrobenzene\n—\n249\n509\nNitrocresols and their alkali metal salts\n—\n250\n510\nNitroderivatives of carbazole\n145\n72\n511\nNitrofurantoin (INN)\n512\n251\n512\nN-(5-Nitro-2-furfurylidene)-1-aminohydantoin\n511\n251\n513\n3-(5-Nitrofurfurylideneamino)oxazolidin-2-one\n355\n252\n514\nNitroglycerine\n363, 615\n253\n515\nNitrosamines\n—\n410\n516\nNitrostilbenes, their homologues and derivatives\n—\n256\n517\nNitroxoline (INN) and its salts\n398\n209\n518\nN,N,N,N’,N’,N”,N”,N”-Nonaethyl-2,2’2”-(benzene-1,2,3-triyltrioxy)-tris(ethanaminium) triiodide\n360\n329\n519\nNoradrenaline and its salts\n32, 520\n257\n520\nNorepinephrine (INN) and its salts\n32, 519\n257\n521\nNoscapine (INN) and its salts\n503\n258\n522\nNux Vomica and its preparations\n(661)\n305\n523\nOctamoxin (INN) and its salts\n387\n202\n524\nOctamylamine (INN) and its salts\n—\n267\n525\nOctodrine (INN) and its salts\n34, 288\n28\n526\nOestrogens\n—\n260\n527\nOleandrin\n—\n261\n528\n2-(1,3,4-Oxadiazol-2-yl)phenol\n344\n208\n529\n[Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts\n24\n132\n530\nOxanamide (INN) and its derivatives\n332\n165\n531\n2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11b-H-benzo[a]quinolizine and its salts\n688\n139\n532\nOxpheneridine (INN) and its salts\n334\n172\n533\nOxyquinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 4\n112, 401, 633\n395\n534\nPadimate A\n47\n381\n535\nParamethasone (INN)\n350\n186\n536\nParaoxon\n263\n170\n537\nParathion (ISO)\n264\n131\n538\nParethoxycaine (INN) and its salts\n259, 411\n179\n539\nPelletierine and its salts\n598\n263\n540\nPemoline (INN) and its salts\n407\n212\n541\nPentachloroethane\n—\n264\n542\nPentaerythritol chloral\n552\n266\n543\nPentaerythritol tetranitrate\n544, 551\n265\n544\nPentaerythrityl tetranitrate (INN)\n543, 551\n265\n545\nPentamethonium bromide (INN)\n(547)\n120\n546\n1,1,3,3,5-Pentamethyl-4,6-dinitroindane\n489\n421\n547\nN,N’-Pentamethylenebis(trimethylammonium) salts\n545\n120\n548\nPentobarbitone and its salts\n(69)\n220\n549\nPerchloroethylene\n692\n314\n550\nPerphenazine (INN) and its salts\n(561)\n320\n551\nPETN\n543, 544\n265\n552\nPetrichloral (INN)\n542\n266\n553\nPhenacemide (INN)\n564\n269\n554\nPhenaglycodol (INN)\n173\n95\n555\nPhenetamine\n226\n112\n556\nPheneturide (INN)\n340, 568\n272\n557\nPhenindone (INN)\n574\n271\n558\nPhenmetrazine (INN), its derivatives and salts\n479\n232\n559\nPhenobarbitone and its salts\n(69)\n220\n560\nPhenolphthalein (INN)\n111\n417\n561\nPhenothiazine (INN) and its compounds\nvarious\n320\n562\nPhenprobamate (INN)\n576\n71\n563\nPhenprocoumon (INN)\n577\n273\n564\nN-Phenylacetylurea\n553\n269\n565\n4-Phenylazophenylene-1,3-diamine citrate hydrochloride\n189\n81\n566\nPhenylbutazone (INN)\n129\n67\n567\n4-Phenylbut-3-en-2-one\n92\n356\n568\n(2-Phenylbutyryl)urea\n340, 556\n272\n569\nN-[2-(α-Phenyl-p-chlorobenzyl)ethyl]morpholine\n265\n270\n570\n1-Phenylcyclopentanecarboxylic acid diethylaminoethyl ester and its salts\n143\n169\n571\n2-Phenycyclopropylamine (trans-form) and its salts\n722\n324\n572\n1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one\n620\n138\n573\no-Phenylenediamine and its salts\n242\n363\n574\n2-Phenylindan-1,3-dione\n557\n271\n575\nα-Phenyl-2-piperidineacetic acid methyl ester and its salts\n475\n175\n576\n3-Phenylpropyl carbamate\n562\n71\n577\n3-(α-Phenylpropyl)-4-hydroxycoumarin\n563\n273\n578\n1-Phenyl-2-(2-pyridylamino)ethanol\n346, 582\n274\n579\n2-[1-Phenyl-1-(2-pyridyl)ethoxy]-ethyldimethylamine and its salts\n311\n176\n580\n2-Phenylquinoline-4-carboxylic acid its salts and derivatives and salts of those derivatives\n191\n8\n581\n6-Phenyl-2,4,7-triaminopteridine and its salts\n725\n275\n582\nPhenyramidol\n346, 578\n274\n583\nPhosphides, metal\n—\n279\n584\nPhosphorus\n—\n279\n585\n4-Phosphoryloxy-N,N-dimethyltryptamine\n622\n278\n586\n3-Phthalimidopiperidine-2,6-dione and its salts\n704\n280\n587\nPhthalylsulphathiazole (INN) and its salts\n(678)\n307\n588\nPhysostigma veneriosum Balf.\n137\n281\n589\nPhysostigmine and its salts\n319\n166\n590\nPhytolacca spp and their preparations\n—\n374\n591\nPicric acid\n745\n268\n592\nPicrotoxin\n197\n282\n593\nPilocarpine and its salts\n—\n283\n594\nPilocarpus jaborandi Holmes and its galenical preparations\n—\n311\n595\nPipazetate (INN) and its salts\n596\n118\n596\n2-(2-Piperidinoethoxy)ethyl 10-thia-1,9-diazaanthracene-9-carboxylate and its salts\n95\n118\n597\nα-Piperidin-2-ylbenzyl acetate laevorotatory threo-form and its salts\n426\n284\n598\n1-(2-Piperidyl)propan-2-one and its salts\n539\n263\n599\n6-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide, its salts and derivatives\n485\n372\n600\nPipradrol (INN) and its salts\n304\n285\n601\nPiprocurarium idodide (INN)\n256\n137\n602\nPoldine metilsulfate (INN) (Poldine methylsulphate)\n84\n239\n603\nPolyacetaldehyde\n444\n223\n604\nPotassium cyanide\n(388, 390, 409)\n111\n605\nPotassium nitroferricyanide\n(15), 606\n255\n606\nPotassium nitroprusside\n(15), 605\n255\n607\nPramocaine (INN)\n608\n405\n608\nPramoxine\n607\n405\n609\nProbenecid (INN)\n308\n161\n610\nProcainamide (INN) its salts and derivatives\n29\n25\n611\nProchlorperazine (INN) and its salts\n(561)\n320\n612\nProgestogens\n—\n194\n613\nPromazine (INN) and its salts\n(561)\n320\n614\nPromethazine (INN) and its salts\n(561)\n320\n615\nPropane-1’,2,3-triyl trinitrate\n363, 514\n253\n616\nPropatylnitrate (INN)\n109\n206\n617\n1-Propyl-3-(4-chlorobenzenesulphonyl)urea\n181\n79\n618\n2-Propylpiperidine\n212\n290\n619\n1-(2-Propynyl)cyclohexyl carbamate\n383\n115\n620\nPropyphenazone(INN)\n572\n138\n621\nPrunus laurocerasus L.\n156\n291\n622\nPsilocybine (INN)\n585\n278\n623\nPsoralen (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg\n(357)\n358\n624\nPyrethrum album L. and its galenical preparations\n—\n345\n625\nPyrianisamine maleate\n453\n346\n626\nPyribenzamine\n95, 748\n347\n627\n2-(N-2-Pyridyl-N-2-thienylamino)ethyl-dimethylamine and its salts\n448\n144\n628\nPyrithione disulphide + magnesium sulphate\n310\n396\n629\nPyrithione sodium\n—\n369\n630\nPyrocatechol\n79, 152\n408\n631\nPyrogallol\n80\n409\n632\nQuinalbarbitone and its salts\n(69)\n220\n633\nQuinolin-8-ol (except for the uses provided for in entry number 51 in Part I of Schedule 4)\n(401, 533)\n395\n634\nRadioactive substances (within the meaning of Article 1 of Council Directive 96/29/Euratom(a) laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation)\n—\n293\n635\nRauwlfia serpentine alkaloids and their salts\n636\n15\n636\nReserpine (INN) and its salts\n(635)\n15\n637\nRetinoic acid and its salts\n724, 760\n375\n638\nSafrole (except natural content of essences in cases where the concentration of such safrole in the cosmetic product does not exceed— (a) in the case of oral hygiene or dental products other than toothpaste intended specifically for children, 50 mg/kg; or (b) in the case of products other than oral hygiene or dental products, 100 mg/kg)\n—\n360\n639\nα-Santonin\n380\n214\n640\nSchoenocaulon officinale Lind. (seeds and galenical preparations)\n—\n332\n641\nScopolamine, its salts and derivatives\n403\n295\n642\nSecbutobarbitone and its salts\n(69)\n220\n643\nSecondary alkyl- and alkanolamines and their salts\n108, 255, 274\n411\n644\nSelenium and its compounds (except when permitted under the restrictions laid down in Part I of Schedule 4)\n—\n297\n645\nSodium cyanide\n(388, 390, 409)\n111\n646\nSodium hexacyclonate (INN)\n396\n114\n647\nSodium nitroferricyanide\n(15), 648\n255\n648\nSodium nitroprusside\n(15), 647\n255\n649\nSolanum nigrum L. and its galenical preparations\n–\n298\n650\nSpanish Fly\n139\n69\n651\nSparteine (INN) and its salts\n432\n299\n652\nSpironolactone (INN)\n10\n4\n653\nSquill and its preparations\n752\n330\n654\nStramonium and its preparations\n232\n301\n655\nStrontium lactate\n-\n402\n656\nStrontium nitrate\n-\n403\n657\nStrontium polycarboxylate\n-\n404\n658\nStrophanthines and their aglucones and their respective derivatives\n-\n302\n659\nStrophanthus species and their galenical preparations\n-\n303\n660\nStrychnine and its salts\n-\n304\n661\nStrychnos species and their galenical preparations\n522\n305\n662\nSuccinonitrile\n-\n150\n663\nSuccinylsulphathiazole and its salts\n(678)\n307\n664\nSulfinpyrazone (INN)\n303\n155\n665\nSulphacetamide and its salts\n(678)\n307\n666\nSulphadiazine and its salts\n(678)\n307\n667\nSulphadimethoxine and its salts\n(678)\n307\n668\nSulphadimidine and its salts\n(678)\n307\n669\nSulphafurazole and its salts\n(678)\n307\n670\nSulphaguanidine and its salts\n(678)\n307\n671\nSulphamethizole and its salts\n(678)\n307\n672\nSulphamethoxazole and its salts\n(678)\n307\n673\nSulphamethoxydiazine and its salts\n(678)\n307\n674\nSulphamethoxypyridazine and its salts\n(678)\n307\n675\nSulphanilamide and its salts\n(678)\n307\n676\nSulphapyridine and its salts\n(678)\n307\n677\nSulphathiazole and its salts\n(678)\n307\n678\nSulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts\n665-677\n307\n679\nSulthiame\n680, 699\n308\n680\nSultiame (INN)\n679, 699\n308\n681\nSympathomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe\n44\n21\n682\nTefazoline (INN) and its salts\n698\n237\n683\nTellurium and its compounds\n-\n312\n684\nTEPP (ISO)\n696\n276\n685\n2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline and its salts\n766\n313\n686\n4-tert-Butylphenol\n-\n340\n687\n4-tert-Butylpyrocatechol\n-\n341\n688\nTetrabenazine (INN) and its salts\n531\n139\n689\nTetrabromosalicylanilides\n-\n367\n690\nTetracaine (INN) and its salts\n280\n63\n691\n2,3,7,8-Tetrachlorodibenzo-p-dioxin\n-\n367\n692\nTetrachloroethylene\n549\n314\n693\nTetrachloromethane\n147\n315\n694\nTetrachlorosalicylanilides\n-\n348\n695\nTetraethylammonium bromide\n703\n61\n696\nTetraethyl pyrophosphate\n684\n276\n697\n(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol and its salts\n59\n42\n698\n2-(5,6,7,8-Tetrahydro-1-naphthylmethylmethyl)-2-imidazoline and its salts\n682\n237\n699\n4-(Tetrahydro-2H-1,2-thiazin-2-yl)-benzenesulphonamide S,S-dioxide\n679, 680\n308\n700\nTetrahydrozoline and its salts\n-\n394\n701\nN,2,3,3-Tetramethyl-2-nocamphanamine\n437\n229\n702\nTetramethylthiuram disulphide\n713\n162\n703\nTetrylammonium bromide (INN)\n695\n61\n704\nThalidomide (INN) and its salts\n586\n280\n705\nThallium and its compounds\n-\n317\n706\nThevetia neriifolia Juss., glycoside extract\n-\n318\n707\nThiamazole (INN)\n472, 474\n233\n708\n2,2’-Thiobis(4,6-dichlorophenol)\n113\n352\n709\nThiopentone and its salts\n(69)\n220\n710\nThioridazine (INN) and its salts\n(561)\n320\n711\nThiotepa (INN)\n726\n310\n712\nThiourea and its derivatives (except those listed Part I of Schedule 4)\n-\n321\n713\nThiram (ISO)\n702\n162\n714\nThiuram disulphides\n-\n354\n715\nThuiram monosulphides\n-\n353\n716\nThyropropic acid (INN) and its salts\n394\n9\n717\nTolboxane (INN)\n720\n177\n718\nTolbutamide (INN)\n132\n65\n719\nToluidines, their isomers, salts and halogenated and sulphonated derivatives\n40\n32\n720\np-Tolyboric acid ester of 2-methyl-2-propylpropane-1,3-diol\n717\n177\n721\n3-o-Tolyoxypropane-1,2-diol\n(439)\n322\n722\nTranylcypromine (INN) and its salts\n571\n324\n723\nTretamine (INN)\n727\n328\n724\nTretinoin (INN) and its salts\n637, 760\n375\n725\nTriamterene (INN) and its salts\n581\n275\n726\nTri(aziridin-1-yl)phosphine sulphide\n711\n310\n727\n2,4,6-Tri(aziridin-l-yl)-1,3-triazine\n723\n328\n728\n2,2,2-Tribromeothanol\n(729)\n326\n729\nTribromoethyl alcohol\n728\n326\n730\nTribromsalan (INN)\n731\n373\n731\n3,4’,5-Tribromosalicylanilde\n730\n373\n732\nTrichlormethine (INN) and its salts\n749\n327\n733\nTrichloroacetic acid\n-\n10\n734\n1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane\n194, 233\n123\n735\n2,2,2-Trichloroethane-1,1-diol\n157\n77\n736\nTrichloromethane\n167\n366\n737\nN-(Trichloromethylthio)cyclohex-4-ene-1,2-dicarboximide\n141\n370\n738\nTrichloronitromethane\n177\n325\n739\nTricresyl phosphate\n750\n277\n740\nTrifluoperazine (INN) and its salts\n(561)\n320\n741\nTrifluperidol (INN)\n349\n188\n742\n3,3’,5-Triiodothyroacetic acid and its salts\n393\n5\n743\n3,4,5-Trimethoxyphenethylamine and its salts\n442\n222\n744\n2.2,6-Trimethyl 1-4-piperidyl benzoate and its salts\n75\n51\n745\n2,4,6-Trinitrophenol\n591\n268\n746\nTrioxysalen (INN) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg\n(357)\n358\n747\nTriparanol (INN)\n171\n92\n748\nTripelennamine (INN)\n95, 626\n347\n749\nTris(2-chloroethyl)amine\n732\n327\n750\nTritolyl phosphate\n739\n277\n751\nTauminoheptane (INN), its isomers and salts\n30\n27\n752\nUrginea scilla Stern. and its galenical preparations\n653\n330\n753\nUrocanic acid\n(406)\n418\n754\nVaccines, toxins and serums listed in the Annex to Council Directive No. 75/319/EEC(a)\n-\n323\n755\nValnoctamide (INN)\n339\n184\n756\nVeratrine, its salts and galenical preparations\n-\n331\n757\nVeratrun spp and their preparations\n-\n333\n758\nVinyl chloride monomer\n-\n334\n759\nVinylidene chloride\n(7,250)\n126\n760\nVitamin A acid and its salts\n637, 724\n375\n761\nVitamins D2 and D3\n138, 186, 317\n335\n762\nWarfarin (ISO) and its salts\n3, 399\n203\n763\nXanthates\n16\n336\n764\nXanthinol\n392\n135\n765\nXylidines, their isomers, salts and halogenated and sulphonated derivatives\n41\n33\n766\nXylometazoline (INN) and its salts\n685\n313\n767\nYohimbine and its salts\n-\n337\n768\nZirconium and its compounds (except aluminium chloride hyroxide complexes and aluminium zirconium chloride hydroxide glycine complexes under the conditions laid down in Part I of Schedule 4 and zirconium lakes, salts and pigments prepared from those colouring agents identified in column 1 Part I of Schedule 5 by “*” immediately after the name or colour index number)\n-\n391\n769\nZoxazolamine (INN)\n28\n24",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 3 Pt. 1 in force at 11.9.2004, see reg. 1(1)"
    }
  ],
  "outstanding_effects": [
    {
      "type": "am",
      "affecting": "uksi/2005/1815",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) Regulations 2005"
    },
    {
      "type": "am",
      "affecting": "uksi/2005/1815",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) Regulations 2005"
    },
    {
      "type": "words omitted",
      "affecting": "uksi/2004/2988",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) (No.2) Regulations 2004"
    },
    {
      "type": "am",
      "affecting": "uksi/2005/3346",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) (No. 2) Regulations 2005"
    },
    {
      "type": "am",
      "affecting": "uksi/2005/3346",
      "affecting_title": "The Cosmetic Products (Safety) (Amendment) (No. 2) Regulations 2005"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2004/2152/schedule/3/part/1",
    "retrieved_at": "2026-10-29T05:20:02.092817+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}